Sunbelt Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.8K Sell
647
-15
-2% -$1.24K ﹤0.01% 1007
2025
Q4
$56.4K Buy
662
+7
+1% +$574 ﹤0.01% 965
2025
Q3
$50.9K Buy
655
+55
+9% +$4.3K ﹤0.01% 998
2025
Q2
$44.4K Hold
600
﹤0.01% 972
2025
Q1
$43.5K Hold
600
﹤0.01% 943
2024
Q4
$44.5K Sell
600
-29
-5% -$2.03K ﹤0.01% 970
2024
Q3
$41.5K Hold
629
﹤0.01% 989
2024
Q2
$58.1K Hold
629
0.01% 863
2024
Q1
$60.1K Hold
629
0.01% 834
2023
Q4
$48K Hold
629
0.01% 828
2023
Q3
$43.6K Hold
629
0.01% 838
2023
Q2
$59.3K Buy
629
+29
+5% +$2.52K 0.01% 752
2023
Q1
$48.9K Buy
+600
New +$47.2K 0.01% 750
2020
Q1
Sell
-3,384
Closed -$263K 459
2019
Q4
$263K Buy
+3,384
New +$264K 0.03% 473

Other funds holding EW

Sunbelt Securities's EW Position: Q1 2026 in Review

Sunbelt Securities reduced its Edwards Lifesciences (EW) stake by 2.3% in Q1 2026, selling an estimated $1.24K and leaving 647 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Sunbelt Securities first reported a position in EW in Q4 2019 and has held it in 14 quarters since. The position peaked at $263K in Q4 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Sunbelt Securities held 647 shares of Edwards Lifesciences worth $51.8K as of Q1 2026.
  • Sunbelt Securities sold 15 Edwards Lifesciences shares in Q1 2026, an estimated $1.24K.
  • Edwards Lifesciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1007 holding.
  • Sunbelt Securities first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 14 quarters since.
  • Sunbelt Securities's Edwards Lifesciences position peaked at $263K in Q4 2019.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.